Michael Söderman, Department of Neuroradiology, Karolinska University Hospital, Stockholm, Sweden told delegates at the European Society of Minimally Invasive Neurological Therapy (ESMINT; 5–8 September, Nice, France) congress that there are studies that indicate the benefit of mechanical thrombectomy if it is performed with a collaborative team of interventional neuroradiologists, neurologists and neurosurgeons and in dedicated stroke centres.
The first US implants of a novel deep brain stimulation system in research that is investigating the brain’s response to the therapy has been announced by Medtronic.
Using a novel stroke rehabilitation device that converts an individual’s thoughts to electrical impulses to move upper extremities has reported improvements in stroke patients’ motor function and ability to perform day-to-day activities. Results of the study were presented at the annual meeting of the Radiological Society of North America (RSNA; 1–6 December, Chicago, USA).
A study, published online first in the Journal of Neurointerventional Surgery has found that a single coaxial dual balloon microcatheter can be used to achieve coil placement and neck remodelling in selected oblong intracranial and cervical arterial aneurysms.
InspireMD has announced that its new CGuard carotid embolic protection system has been successfully implanted in recent procedures, including a patient treated during the 17(th) Annual Symposium on Interventional Cardiology & Angiology held in Hamburg, Germany on 1 February 2014.
A build-up of plaque in the carotid artery above the neck was associated with an increased risk of stroke for older white patients in a study by Daniel Bos, Erasmus Medical Centre, Rotterdam, the Netherlands, and colleagues.
The Brain Research Foundation has announced three recipients of its 2014 Scientific Innovations Awards programme for researchers investigating novel pathways to detect, treat and better comprehend serious neural diseases such as Parkinson’s and schizophrenia.
A Norwegian study has found that cerebral, regional magnetic resonance imaging (MRI) can lead to an increase in incidence rates of intracranial tumour diagnosis.
The ALS Association has announced the awarding of five new grants to investigate the causes and treatment of amyotrophic lateral sclerosis (ALS). The ALS Association identified the focus of each of these grants as areas with high potential for progress.
The results of a study published in the Journal of NeuroInterventional Surgery have shown that carotid stenting without post-dilation is safe and effective.
Brain surgeon Hrayr Shahinian (the Skull Base Institute, Los Angeles, USA), a pioneer in minimally invasive surgery, and NASA’s Jet Propulsion Laboratory in Pasadena, USA, have introduced the next generation of high-tech surgical instruments to remove tumours and treat other brain abnormalities.
New data has been reported supporting the clinical validation of MS Precise (DioGenix), a next-generation sequencing assay for the identification of patients with multiple sclerosis at first clinical presentation.
In final guidance, the National Institute for Health and Care Excellence (NICE) has recommended the use of Genzyme’s multiple sclerosis drug teriflunomide (also called Aubagio) for adults with relapsing-remitting multiple sclerosis.
In NHS guidance, the National Institute for Health and Care Excellence (NICE) has announced the results from clinical trials investigating a portable transcranial magnetic device for the treatment of migraine (SpringTMS, eNeura). The trials aimed to prevent or treat acute migraine among sufferers of pain, visual disturbance or sickness.
The study: “Examination of cognitive fatigue in multiple sclerosis using functional magnetic resonance imaging and diffusion tensor imaging” by Helen M Genova, research scientist in neuropsychology and neuroscience research at Kessler Foundation, USA, and others sheds light on the mechanisms of underlying cognitive fatigue in patients with multiple sclerosis.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos